Phase II study of weekly docetaxol combined with cisplatin and 5-FU [fluorouracil] in patients with advanced gastric cancer
Phase of Trial: Phase II
Latest Information Update: 26 Apr 2011
At a glance
- Drugs Cisplatin (Primary) ; Docetaxel (Primary) ; Fluorouracil (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- Acronyms DCF-AGC
- 29 Jan 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 25 Dec 2007 New trial record.